Microbial Colonization

1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Paratek Pharmaceuticals
1 program
1
Omadacycline InjectionPhase 41 trial
Active Trials
NCT05515562CompletedEst. Jul 2023
Verona Pharma
Verona PharmaUK - London
1 program
Microbiome evaluationN/A1 trial
Active Trials
NCT04274972Unknown20Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Paratek PharmaceuticalsOmadacycline Injection
Verona PharmaMicrobiome evaluation

Clinical Trials (2)

Total enrollment: 20 patients across 2 trials

Effects of Intravenous (IV) Omadacycline on Gut Microbiome

Start: Mar 2023Est. completion: Jul 2023
Phase 4Completed
NCT04274972Verona PharmaMicrobiome evaluation

The Microbiome of Pancreatic Cancer: "PANDEMIC" Study

Start: Feb 2020Est. completion: Dec 202420 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space